戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 he human epidermal growth factor receptor 2/ neu gene.
2 (1,2) There was no amplification of the HER2/neu gene.
3 ymine on the nontemplate strand of the HER-2/neu gene.
4 le helix in the coding sequence of the HER-2/neu gene.
5                   In the present study HER-2/neu gene amplification and expression was determined in
6 mely reliable in detecting presence of HER-2/neu gene amplification and should have clinical utility.
7 s to determine whether the presence of HER-2/neu gene amplification and/or overexpression in benign b
8 cer patients (N = 900) were tested for HER-2/neu gene amplification by FISH in paraffin-embedded, for
9 tive and specific method for assessing HER-2/neu gene amplification in archival tissue and to test wh
10           Our results demonstrate that HER-2/neu gene amplification in the absence of adjuvant therap
11                  Case patients who had HER-2/neu gene amplification in their malignant tumor were mor
12       Fourteen percent of patients had HER-2/neu gene amplification in tumors compared with levels in
13  blotting procedures, FISH analysis of HER-2/neu gene amplification showed a sensitivity of 98% and a
14                                        HER-2/neu gene amplification was assessed by differential PCR,
15                                        HER-2/neu gene amplification was determined by FISH in 140 arc
16    The accuracy of the FISH assays for HER-2/neu gene amplification was high, 97.4% for the Vysis Pat
17 a bright-field assay for assessment of HER-2/neu gene amplification was investigated.
18           IMH false-positive cases (no Her-2/neu gene amplification) occurred with both HercepTest (2
19 ight-field assay for the assessment of HER-2/neu gene amplification.
20 on by FISH to determine the utility of HER-2/neu gene amplification.
21 f UPSCs but was rarely correlated with Her-2/neu gene amplification.
22 d that 79% (38 of 48) of 3+ cases were Her-2/neu gene amplified, but only 17% (seven of 41) of 2+ cas
23 ains in the EGFR and human EGFR type 2 (Her2/neu) genes and analyzed the expression of EGFR, EGFR del
24 xamining the amplification of the ERBB2/Her2-neu gene, and evaluating the expression patterns of six
25 nhibit transcription elongation in the HER-2/neu gene, and show that covalent modification of the DNA
26 (IHC) assays and not amplified for the HER-2/neu gene by fluorescence in situ hybridization were stud
27    Despite their proximity, CRD-BP and HER-2/neu genes can be amplified independently.
28                                    The HER-2/neu gene codes for a membrane receptor protein that is h
29                          In the native HER-2/neu gene, covalent attachment of the triplex-forming oli
30 ransgenic mice harboring an activated MMTV-c-neu gene did not result in tumor regression.
31 Amplification or overexpression of the HER-2/neu gene in breast cancers is associated with aggressive
32 hown to inhibit transcription from the HER-2/neu gene in vitro, whereas their use in vivo has been st
33 st cancers, we introduced the human c-erbB-2/neu gene into the very low p185-expressing MDA-MB435 hum
34                               The HER2/ERBB2/NEU gene is also frequently overexpressed in breast canc
35 rom chromosome 17q11-12 containing the HER-2/Neu gene is amplified in about 25% of breast cancer.
36                    The enzyme encoded by the neuS gene is membrane-associated and has been suggested
37  surface and encodes for the nanT, neuA, and neuS genes necessary for harvesting and presenting SA.
38 mplification and overexpression of the HER-2/neu gene occurs in 25-30% of human breast cancers.
39 A1 or functional overexpression of the HER-2/neu gene presumably contributes to the somatic phenotype
40                        Antibody to the Her-2/neu gene product has been shown to inhibit the growth of
41  with a synthetic peptide from the rat HER-2/neu gene product, which represents an epitope for CTLs i
42  synthesis in cells overexpressing the HER-2/neu gene product.
43                 Our results suggest that the neuS gene product of E. coli K92 catalyzes the synthesis
44 hybridization (FISH)-based analysis of HER-2/neu gene status were performed on formalin-fixed, paraff
45 The conditional expression of activated HER2/neu gene under its endogenous promoter in the mammary ep
46                                      The K92 neuS gene was used to transform the K1 strain of E. coli